- Home
- LBTYK vs OGN Comparison
LBTYK vs OGN Comparison
Compare LBTYK & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBTYK
- OGN
- Stock Information
- Founded
- LBTYK 2004
- OGN 1923
- Country
- LBTYK Bermuda
- OGN United States
- Employees
- LBTYK N/A
- OGN N/A
- Industry
- LBTYK Cable & Other Pay Television Services
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- LBTYK Telecommunications
- OGN Health Care
- Exchange
- LBTYK Nasdaq
- OGN Nasdaq
- Market Cap
- LBTYK 4.3B
- OGN 4.0B
- IPO Year
- LBTYK N/A
- OGN N/A
- Fundamental
- Price
- LBTYK $11.91
- OGN $15.48
- Analyst Decision
- LBTYK
- OGN Hold
- Analyst Count
- LBTYK 0
- OGN 5
- Target Price
- LBTYK N/A
- OGN $20.80
- AVG Volume (30 Days)
- LBTYK 1.4M
- OGN 2.9M
- Earning Date
- LBTYK 01-01-0001
- OGN 02-13-2025
- Dividend Yield
- LBTYK N/A
- OGN 7.23%
- EPS Growth
- LBTYK N/A
- OGN N/A
- EPS
- LBTYK 4.23
- OGN 3.33
- Revenue
- LBTYK $4,341,900,000.00
- OGN $6,403,000,000.00
- Revenue This Year
- LBTYK $1.76
- OGN $2.06
- Revenue Next Year
- LBTYK N/A
- OGN $1.85
- P/E Ratio
- LBTYK $2.55
- OGN $4.65
- Revenue Growth
- LBTYK 5.49
- OGN 2.24
- 52 Week Low
- LBTYK $10.83
- OGN $13.87
- 52 Week High
- LBTYK $22.14
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- LBTYK 50.21
- OGN 50.46
- Support Level
- LBTYK $10.83
- OGN $15.26
- Resistance Level
- LBTYK $11.44
- OGN $15.90
- Average True Range (ATR)
- LBTYK 0.31
- OGN 0.63
- MACD
- LBTYK 0.11
- OGN 0.04
- Stochastic Oscillator
- LBTYK 87.80
- OGN 35.19
About LBTYK Liberty Global Ltd. Class C
Liberty Global is a holding company with interests in several telecom companies in the UK, Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty is the owner of the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile-network-operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.